Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2025-12-26 @ 3:07 AM
Study NCT ID:
NCT00321620
Status:
COMPLETED
Last Update Posted:
2018-08-29
First Post:
2006-05-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2009-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02-24
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-02
First Submit QC Date:
None
Study First Post Date:
2006-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-10
Results First Submit QC Date:
None
Results First Post Date:
2014-03-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-07-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-08-01
Last Update Post Date:
2018-08-29
Last Update Post Date Type:
ACTUAL